These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19190965)

  • 41. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
    Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
    Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence.
    Yalcin S; Kilickap S; Portakal O; Arslan C; Hascelik G; Kutluk T
    Hepatogastroenterology; 2010; 57(104):1395-8. PubMed ID: 21443092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.
    Tkaczuk KH; Goloubeva O; Tait NS; Feldman F; Tan M; Lum ZP; Lesko SA; Van Echo DA; Ts'o PO
    Breast Cancer Res Treat; 2008 Sep; 111(2):355-64. PubMed ID: 18064568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low number of detectable circulating tumor cells in non-metastatic colon cancer.
    Thorsteinsson M; Söletormos G; Jess P
    Anticancer Res; 2011 Feb; 31(2):613-7. PubMed ID: 21378346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
    Budd GT
    Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary tumor resection improves the survival of younger patients with metastatic breast cancer.
    Shien T; Kinoshita T; Shimizu C; Hojo T; Taira N; Doihara H; Akashi-Tanaka S
    Oncol Rep; 2009 Mar; 21(3):827-32. PubMed ID: 19212646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development.
    Urtishak S; Alpaugh RK; Weiner LM; Swaby RF
    Biomark Med; 2008 Apr; 2(2):137-45. PubMed ID: 20477435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
    Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTCs hemodialysis: can it be a new therapy for breast cancer?
    Wang X; Sun Q; Mao F; Shen S; Huang L
    Med Hypotheses; 2013 Jan; 80(1):99-101. PubMed ID: 23183422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
    Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
    Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.